Wij, en derde partijen, maken op onze website gebruik van cookies. Wij gebruiken cookies om ervoor te zorgen dat onze website goed functioneert, om jouw voorkeuren op te slaan, om inzicht te verkrijgen in bezoekersgedrag, maar ook voor marketing en social media doeleinden (laten zien van gepersonaliseerde advertenties). Door op ‘Accepteren’ te klikken, ga je akkoord met het gebruik van alle cookies. In onze Cookieverklaring kun je meer lezen over de cookies die wij gebruiken en kun je jouw voorkeuren opslaan of wijzigen. Door ‘Weigeren’ te klikken ga je alleen akkoord met het gebruik van functionele cookies.


Immune checkpoint inhibitors (ICIs) have been the largest breakthrough in oncology in the last decade. However, they are effective for only a minority of patients and can cause severe immune-mediated toxicities. Within the UNICIT biobank, we have collected sequential blood, feces, and tissue biopsy samples from more than 600 patients treated with ICIs. This unique resource allows you to investigate the mechanisms behind ICI toxicity and treatment resistance and identify factors that could improve patient outcomes.
As a postdoctoral researcher, you will join the research group of Prof. Karijn Suijkerbuijk at the Department of Medical Oncology. The group focuses on clinical and translational research in melanoma and cancer immunotherapy, with a strong emphasis on immune checkpoint inhibitors.
You will conduct a research project on ICI toxicity and resistance under the supervision of Prof. Karijn Suijkerbuijk. Alongside your own research, you will contribute to collaborative projects, supervise junior researchers and PhD candidates, and help develop new research proposals to secure future funding.
Key responsibilities
As a postdoctoral researcher, you will:
The UMC Utrecht Cancer Center is dedicated to improving outcomes for patients with cancer through innovative research and close collaboration between basic, translational, and clinical scientists.
UMC Utrecht is one of the top melanoma reference centers in the Netherlands and plays a prominent role in research on immune checkpoint inhibitor (ICI) toxicity and treatment response prediction. You will work in a highly collaborative environment with strong connections to the Center for Translational Immunology, led by van Wijk, and the AI Lab for Molecular Medicine, led by de Ridder. In addition, the department maintains extensive national and international collaborations with leading research institutes studying ICI resistance and toxicity.
Interested? Please submit your motivation letter and a detailed curriculum vitae, including the names and contact details of two references.

Wij geloven in de kracht van een divers team waarin ruimte is voor verschillende vaardigheden, expertises, sociale en culturele achtergronden. Wij zijn benieuwd naar jou!
Onze nieuwe collega's werven we zelf. We hebben geen behoefte aan acquisitie.
.jpg)


